Analyst Ratings for Bellerophon Therapeutics (BLPH)

BLPH Rating Summary

  |   Expand Research on BLPH
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/6/2023 Laidlaw Yale Jen Downgrade Hold
(Buy)		 N/A
(N/A)		 7.06
(0.01)		 -99.86% Details
6/5/2023 Brookline Capital Markets Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 7.06
(0.01)		 -99.86% Details